首页> 美国卫生研究院文献>Journal of Clinical Microbiology >Evaluation of a New Chromogenic Agar Medium for Detection of Shiga Toxin-Producing Escherichia coli (STEC) and Relative Prevalences of O157 and Non-O157 STEC in Manitoba Canada
【2h】

Evaluation of a New Chromogenic Agar Medium for Detection of Shiga Toxin-Producing Escherichia coli (STEC) and Relative Prevalences of O157 and Non-O157 STEC in Manitoba Canada

机译:用于检测产志贺毒素的大肠杆菌(STEC)和O157和非O157 STEC相对患病率的新型生色琼脂培养基的评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study assesses the detection performance of CHROMagar STEC medium relative to a reference cytotoxin assay and describes the current relative prevalence of O157 and non-O157 Shiga toxin-producing Escherichia coli (STEC) serotypes within the province of Manitoba, Canada. Over a 10-month period, 205 nonfrozen routine stool submissions to Cadham Provincial Laboratory (CPL) were used to assess the performance of CHROMagar STEC. Of the 205 stools, 14 were identified as true positives by a cytotoxin assay, with resultant CHROMagar STEC sensitivity, specificity, and positive predictive and negative predictive values of 85.7%, 95.8%, 60.0%, and 98.9%, respectively. Using a separate panel of 111 STEC strains, CHROMagar STEC was shown to support the growth of 96 (86.5%) isolates. To assess relative prevalence, attempts were made to isolate by any means all STEC strains identified at CPL over a 17-month period. Of 49 isolates (representing 86.0% of all STEC infections detected), only 28.6% were O157 STEC strains. Of the 35 non-O157 STEC strains, 29 were subjected to further molecular analysis. In contrast to earlier results from our area, carriage of stx2 appears to have increased. Overall, although CHROMagar STEC is not recommended as a primary screen, our results indicate that it is an effective supplemental medium for the isolation of probable STEC strains. Increased isolation of these serotypes is warranted to better understand their prevalence, clinical characteristics, and epidemiology and aid in the development or enhancement of food safety control programs targeting all STEC serotypes.
机译:这项研究评估了CHROMagar STEC培养基相对于参考细胞毒素测定的检测性能,并描述了加拿大曼尼托巴省内O157和非O157产志贺毒素的大肠杆菌(STEC)血清型的当前相对患病率。在10个月的时间内,使用205份常规Cadham省实验室(CPL)的常规非冻结粪便评估了CHROMagar STEC的性能。在205个粪便中,有14个通过细胞毒素测定被鉴定为真阳性,结果CHROMagar STEC的敏感性,特异性以及阳性预测值和阴性预测值分别为85.7%,95.8%,60.0%和98.9%。使用111个STEC菌株的单独面板,证明CHROMagar STEC支持96(86.5%)分离株的生长。为了评估相对患病率,已尝试通过任何方式分离在17个月内CPL鉴定出的所有STEC菌株。在49株分离株中(占检测到的所有STEC感染的86.0%),只有28.6%是O157 STEC菌株。在35个非O157 STEC菌株中,对29个进行了进一步的分子分析。与我们地区的早期结果相比,stx2的转运似乎有所增加。总体而言,尽管不建议将CHROMagar STEC用作主要筛选,但我们的结果表明,它是用于分离可能的STEC菌株的有效补充培养基。有必要增加对这些血清型的隔离,以更好地了解它们的流行情况,临床特征和流行病学,并有助于制定或增强针对所有STEC血清型的食品安全控制计划。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号